Antitumor and Antimetastatic Activity of a Novel Pyrimidin-4-one Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study. (2026). Voprosy Onkologii, 72(4), 2630. https://doi.org/10.37469/0507-3758-2026-72-4-2630